Stock info Aemetis Inc | Filter  Basic-Info

Aemetis Inc

Aemetis Inc has located her head office Cupertino. Aemetis Inc mainly operates in the biotech sector. Mr. Eric A. McAfee is the company' CEO. Mr. Todd A. Waltz runs the company as a CFO. The period from 2006 till the end of 2016 the international sector gained around 59 percent. As from 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

The past year was a good year for Aemetis Inc investors

Over the past year the company' stock lost around 23 percent. Aemetis Inc' stock lost the past 5 years at around 77 percent. Aemetis Inc's revenues between 2011 and 2015 were quite similar and moved between 189,05 million dollars and 146,65 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between -18,3 million dollars and -27,14 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Healthy financed: not so much debt Aemetis Inc

As per the end of 2015 the American company's balance sheet equaled 83,14 million dollars. Of the total balance sheet 118,43 million dollars (142,45 percent) was financed by debt. As per the end of 2015 Aemetis Inc's price/earnings-ratio equaled -4. So investors paid for 1 stock -4 times the earnings per share of 2015. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the biotech company equaled around 50,75 million dollars. At the end of 2015 around 19,82 million stocks were listed.

All the annual reports of Aemetis Inc are available here. More information about Aemetis Inc can be found it's website. .